Patents by Inventor Jia-Hung Lin
Jia-Hung Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250140493Abstract: An icon display module includes a light blocking structure, a first light-emitting element, a second light-emitting element, a first light-guiding pattern structure and a second light-guiding pattern structure. The light blocking structure includes an accommodation space and a first light-blocking part. The accommodation space is divided into a first region and a second region by the first light-blocking part. When the first light-emitting element emits a first light beam, the first light beam is guided by the first light-guiding pattern structure and the second light-guiding pattern structure and projected on the target. Consequently, a first icon and a second icon are shown on the target. When the second light-emitting element emits a second light beam, the second light beam is guided by the first light-guiding pattern structure and projected to the target. Consequently, the first icon is shown on the target.Type: ApplicationFiled: November 22, 2023Publication date: May 1, 2025Inventors: Jia-Hung Lin, Hui-Ling Lin
-
Patent number: 12288652Abstract: An icon display module includes a light blocking structure, a first light-emitting element, a second light-emitting element, a first light-guiding pattern structure and a second light-guiding pattern structure. The light blocking structure includes an accommodation space and a first light-blocking part. The accommodation space is divided into a first region and a second region by the first light-blocking part. When the first light-emitting element emits a first light beam, the first light beam is guided by the first light-guiding pattern structure and the second light-guiding pattern structure and projected on the target. Consequently, a first icon and a second icon are shown on the target. When the second light-emitting element emits a second light beam, the second light beam is guided by the first light-guiding pattern structure and projected to the target. Consequently, the first icon is shown on the target.Type: GrantFiled: November 22, 2023Date of Patent: April 29, 2025Assignee: Primax Electronics Ltd.Inventors: Jia-Hung Lin, Hui-Ling Lin
-
Publication number: 20250041357Abstract: A lactic acid bacterial composition for modulating immune cell differentiation and/or reducing pro-inflammatory cytokine secretion includes: (a) a Limosilactobacillus reuteri GL-104 strain; and (b) a Lacticaseibacillus rhamnosus F-1 strain; wherein the GL-104 strain is deposited at the China Center for Type Culture Collection with a deposition number CCTCC M209138, and the F-1 strain is deposited at the China Center for Type Culture Collection with a deposition number CCTCC M2011124. Additionally, a method for treating or preventing allergic rhinitis by administering the foregoing composition to a subject in need thereof is also provided.Type: ApplicationFiled: February 1, 2024Publication date: February 6, 2025Inventors: Hsieh-Hsun Ho, Shin-Yu Tsai, Yi-Wei Kuo, Jia-Hung Lin, Ko-Chiang Hsia, Yu-Hshan Chin
-
Patent number: 12161682Abstract: The present invention provides a topical composition having a fermented product of lactic acid bacteria synbiotics as an active ingredient. The fermented product of lactic acid bacteria synbiotics is obtained by performing a fermenting step with lactic acid bacteria and a deactivating step on a fermenting substrate. The lactic acid bacteria are consisting of Lactobacillus salivarius subsp. salicinius AP-32, Bifidobacterium animalis subsp. lactis CP-9 and Lactobacillus acidophilus TYCA06. The fermenting substrate includes animal protein, plant protein and/or plant extracts. The aforementioned fermented product of lactic acid bacteria synbiotics can effectively inhibit the growth of Staphylococcus aureus and/or Propionibacterium acnes, and can be used in the topical composition.Type: GrantFiled: March 18, 2021Date of Patent: December 10, 2024Assignee: GLAC BIOTECH CO., LTD.Inventors: Hsieh-Hsun Ho, Yi-Wei Kuo, Ching-Wei Chen, Yu-Fen Huang, Jia-Hung Lin
-
Publication number: 20240231514Abstract: A luminous touch pad includes a covering plate, a circuit board, a light guide structure and a first light-shading adhesive. The covering plate includes a first surface and a second surface. The circuit board is located under the covering plate. The circuit board includes a third surface and a fourth surface. The light guide structure is arranged between the covering plate and the circuit board. The light guide structure includes a lateral surrounding surface. An adhesive receiving space is defined by the lateral surrounding surface, a portion of the second surface and a portion of the third surface collaboratively. The first light-shading adhesive is disposed within the adhesive receiving space and arranged around the light guide structure. The first light-shading adhesive is contacted with the portion of the second surface, the portion of the third surface and the lateral surrounding surface.Type: ApplicationFiled: March 13, 2023Publication date: July 11, 2024Inventors: Jia-Hung Lin, Che-Wei Lee, Yu-Zeng Yang, Hui-Ling Lin
-
Patent number: 12016361Abstract: A probiotic culture is prepared by cultivating a probiotic mixture in a collagen solution. The probiotic mixture includes Lactobacillus acidophilus TYCA06 deposited at the China General Microbiological Culture Collection Center (CGMCC) under an accession number CGMCC 15210, Lactobacillus salivarius subsp. salicinius AP-32 deposited at the China Center for Type Culture Collection (CCTCC) under an accession number CCTCC M 2011127, and Bifidobacterium animalis subsp. lactis CP-9 deposited at the CCTCC under an accession number CCTCC M 2014588, in a ratio of colony forming units which ranges from 1:0.125:0.125 to 1:8:8. Use of the probiotic culture for improving skin condition and for inhibiting pathogenic infection is also provided.Type: GrantFiled: April 21, 2022Date of Patent: June 25, 2024Assignee: GLAC BIOTECH CO., LTD.Inventors: Hsieh-Hsun Ho, Ching-Wei Chen, Yu-Fen Huang, Tsai-Hsuan Yi, Yi-Wei Kuo, Jia-Hung Lin, Shin-Yu Tsai
-
Patent number: 12005091Abstract: The present invention discloses a method for maintaining or improving gastrointestinal condition, which includes: administering a lactic acid bacterial composition to a subject in need thereof, wherein the lactic acid bacterial composition comprises: a Lactobacillus paracasei ET-66 strain with a deposition number CGMCC 13514. The present invention also discloses a method for maintaining or improving gastrointestinal condition, which includes: administering a lactic acid bacterial fermentation composition to a subject in need thereof, wherein the lactic acid bacterial fermentation composition comprises: a fermentation product of a Lactobacillus paracasei ET-66 strain.Type: GrantFiled: April 22, 2022Date of Patent: June 11, 2024Assignee: GLAC BIOTECH CO., LTDInventors: Hsieh-Hsun Ho, Wen-Yang Lin, Jui-Fen Chen, Yi-Wei Kuo, Jia-Hung Lin, Chi-Huei Lin, Ching-Wei Chen, Yu-Fen Huang
-
Patent number: 11957722Abstract: The present invention discloses an anti-aging composition, which includes: (a) isolated lactic acid bacterial strains or a fermented product thereof; and (b) an excipient, a diluent, or a carrier; wherein the isolated lactic acid bacterial strains include: Bifidobacterium bifidum VDD088 strains, Bifidobacterium breve Bv-889 strains, and Bifidobacterium longum BLI-02 strains. The present invention further provides a method for preventing aging by administering the foregoing anti-aging composition to a subject in need thereof.Type: GrantFiled: March 7, 2022Date of Patent: April 16, 2024Assignee: GLAC BIOTECH CO., LTDInventors: Hsieh-Hsun Ho, Yi-Wei Kuo, Wen-Yang Lin, Jia-Hung Lin, Yen-Yu Huang, Chi-Huei Lin, Shin-Yu Tsai
-
Patent number: 11911421Abstract: Disclosed herein is a probiotic composition that includes Lactobacillus salivarius subsp. salicinius AP-32, Lactobacillus johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9, which are deposited at the China Center for Type Culture Collection (CCTCC) respectively under accession numbers CCTCC M 2011127, CCTCC M 2011128, and CCTCC M 2014588. A number ratio of Lactobacillus salivarius subsp. salicinius AP-32, Lactobacillus johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 ranges from 1:0.1:0.1 to 1:1:8. Also disclosed herein is use of the probiotic composition for alleviating type 1 diabetes mellitus (T1DM).Type: GrantFiled: November 18, 2021Date of Patent: February 27, 2024Assignee: GLAC BIOTECH CO., LTD.Inventors: Hsieh-Hsun Ho, Wen-Yang Lin, Yi-Wei Kuo, Yen-Yu Huang, Jia-Hung Lin
-
Patent number: 11860397Abstract: A light guide module includes a light guide plate, a light-emitting element and a covering layer. The light guide plate includes plural first light-guiding dots and plural second light-guiding dots. The light-emitting element is installed on a lateral edge part of the light guide plate. The covering layer includes a non-shading region, a separation region and a shading region. The plural first light-guiding dots of the light guide plate are aligned with the non-shading region of the covering layer. The plural second light-guiding dots of the light guide plate are aligned with the shading region of the covering layer. The plural second light-guiding dots are covered by the shading region of the covering layer.Type: GrantFiled: July 12, 2023Date of Patent: January 2, 2024Assignee: PRIMAX ELECTRONICS LTD.Inventor: Jia-Hung Lin
-
Patent number: 11801274Abstract: Disclosed herein is a method for alleviating atopic dermatitis using a composition containing at least one lactic acid bacterial strain. The at least one lactic acid bacterial strain is selected from the group consisting of Lactobacillus salivarius subsp. salicinius AP-32 which is deposited at the China Center for Type Culture Collection (CCTCC) under an accession number CCTCC M 2011127, and Bifidobacterium animalis subsp. lactis CP-9 which is deposited at the CCTCC under an accession number CCTCC M 2014588.Type: GrantFiled: August 10, 2022Date of Patent: October 31, 2023Assignee: GLAC BIOTECH CO., LTD.Inventors: Hsieh-Hsun Ho, Yi-Wei Kuo, Yen-Yu Huang, Jia-Hung Lin, Ko-Chiang Hsia, Ching-Wei Chen, Shin-Yu Tsai
-
Lactic acid bacteria composition for reducing fat and promoting exercise performance and use thereof
Patent number: 11779615Abstract: The present invention provides a lactic acid bacteria composition, which comprises: a Lactobacillus plantarum PL-02 strain, a Lactobacillus acidophilusTYCA06 strain, a Lactobacillus casei CS-773 strain, and a physiologically acceptable excipient, diluent, or carrier. All of the strains are deposited at the China General Microbiological Culture Collection Center.Type: GrantFiled: July 19, 2021Date of Patent: October 10, 2023Assignee: GLAC BIOTECH CO., LTDInventors: Chi-Chang Huang, Mon-Chien Lee, Yi-Ju Hsu, Hsieh-Hsun Ho, Yi-Wei Kuo, Wen-Yang Lin, Jia-Hung Lin, Chi-Huei Lin -
Publication number: 20230310523Abstract: The present invention discloses a method for maintaining or improving gastrointestinal condition, which includes: administering a lactic acid bacterial composition to a subject in need thereof, wherein the lactic acid bacterial composition comprises: a Lactobacillus paracasei ET-66 strain with a deposition number CGMCC 13514. The present invention also discloses a method for maintaining or improving gastrointestinal condition, which includes: administering a lactic acid bacterial fermentation composition to a subject in need thereof, wherein the lactic acid bacterial fermentation composition comprises: a fermentation product of a Lactobacillus paracasei ET-66 strain.Type: ApplicationFiled: April 22, 2022Publication date: October 5, 2023Inventors: Hsieh-Hsun HO, Wen-Yang LIN, Jui-Fen CHEN, Yi-Wei KUO, Jia-Hung LIN, Chi-Huei LIN, Ching-Wei CHEN, Yu-Fen HUANG
-
Patent number: 11759487Abstract: The invention provides a method of increasing an amount of oral immunoglobulin A (IgA) and/or inhibiting oral pathogens in a subject in need thereof, which utilizes a composition including a therapeutically effective amount of probiotics as an effective ingredient. The probiotics include Lactobacillus plantarum LPL28, which can efficiently increase the amount of oral IgA and/or inhibit the oral pathogens, and thus have a potential to prevent teeth cavities and/or periodontal diseases.Type: GrantFiled: October 27, 2021Date of Patent: September 19, 2023Assignee: GLAC BIOTECH CO., LTD.Inventors: Hsieh-Hsun Ho, Wen-Yang Lin, Yi-Wei Kuo, Yen-Yu Huang, Jia-Hung Lin, Chi-Huei Lin, Cheng-Ruei Liu, Shu-Hui Chen
-
Patent number: 11730779Abstract: The present invention provides a lactic acid bacterial composition for inhibiting the activity of Escherichia coli and/or treating or preventing jaundice, the composition including: a Bifidobacterium animalis subsp. lactis CP-9 strain and a Lactobacillus salivarius subsp. salicinius AP-32 strain. The present invention further provides a method for inhibiting growth of Escherichia coli, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof. The present invention additionally provides a method for treating or preventing jaundice, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof.Type: GrantFiled: February 11, 2022Date of Patent: August 22, 2023Assignee: GLAC BIOTECH CO., LTDInventors: Hsieh-Hsun Ho, Yi-Wei Kuo, Jia-Hung Lin, Hui-Shan Wang, Yen-Yu Huang, Wen-Yang Lin, Ko-Chiang Hsia
-
Publication number: 20230201278Abstract: Disclosed herein is a method for alleviating atopic dermatitis using a composition containing at least one lactic acid bacterial strain. The at least one lactic acid bacterial strain is selected from the group consisting of Lactobacillus salivarius subsp. salicinius AP-32 which is deposited at the China Center for Type Culture Collection (CCTCC) under an accession number CCTCC M 2011127, and Bifidobacterium animalis subsp. lactis CP-9 which is deposited at the CCTCC under an accession number CCTCC M 2014588.Type: ApplicationFiled: August 10, 2022Publication date: June 29, 2023Inventors: Hsieh-Hsun HO, Yi-Wei KUO, Yen-Yu HUANG, Jia-Hung LIN, Ko-Chiang HSIA, Ching-Wei CHEN, Shin-Yu TSAI
-
Publication number: 20230173000Abstract: The present invention discloses an anti-aging composition, which includes: (a) isolated lactic acid bacterial strains or a fermented product thereof; and (b) an excipient, a diluent, or a carrier; wherein the isolated lactic acid bacterial strains include: Bifidobacterium bifidum VDD088 strains, Bifidobacterium breve Bv-889 strains, and Bifidobacterium longum BLI-02 strains. The present invention further provides a method for preventing aging by administering the foregoing anti-aging composition to a subject in need thereof.Type: ApplicationFiled: March 7, 2022Publication date: June 8, 2023Inventors: Hsieh-Hsun Ho, Yi-Wei Kuo, Wen-Yang Lin, Jia-Hung Lin, Yen-Yu Huang, Chi-Huei Lin, Shin-Yu Tsai
-
Publication number: 20230149480Abstract: The present invention provides a lactic acid bacterial composition for inhibiting the activity of Escherichia coli and/or treating or preventing jaundice, the composition including: a Bifidobacterium animalis subsp. lactis CP-9 strain or a Lactobacillus salivarius subsp. salicinius AP-32 strain. The present invention further provides a method for inhibiting growth of Escherichia coli, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof. The present invention additionally provides a method for treating or preventing jaundice, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof.Type: ApplicationFiled: February 11, 2022Publication date: May 18, 2023Inventors: Hsieh-Hsun HO, Yi-Wei KUO, Jia-Hung LIN, Hui-Shan WANG, Yen-Yu HUANG, Wen-Yang LIN, Ko-Chiang HSIA
-
Publication number: 20230131386Abstract: Disclosed herein is a probiotic culture prepared by cultivating a probiotic mixture in a collagen solution. The probiotic mixture includes, in a number ratio of, Lactobacillus acidophilus TYCA06 deposited at the China General Microbiological Culture Collection Center (CGMCC) under an accession number CGMCC 15210, to Lactobacillus salivarius subsp. salicinius AP-32 deposited at the China Center for Type Culture Collection (CCTCC) under an accession number CCTCC M 2011127, and to Bifidobacterium animalis subsp. lactis CP-9 deposited at the CCTCC under an accession number CCTCC M 2014588, which ranges from 1:0.125:0.125 to 1:8:8. Also disclosed herein is use of the probiotic culture for improving skin condition and for inhibiting pathogenic infection.Type: ApplicationFiled: April 21, 2022Publication date: April 27, 2023Inventors: Hsieh-Hsun HO, Ching-Wei CHEN, Yu-Fen HUANG, Tsai-Hsuan YI, Yi-Wei KUO, Jia-Hung LIN, Shin-Yu TSAI
-
Publication number: 20230000930Abstract: A composition, which comprises at least one of an AP-32 strain of Lactobacillus salivarius subsp. salicinius, a BLI-02 strain of Bifidobacterium longum subsp. infantis and fermentation metabolites thereof, has a physiological activity of elevating ability of brain tissue. The present invention may be used in form of a food composition or a pharmaceutical composition to elevate the ability of brain tissue.Type: ApplicationFiled: April 22, 2022Publication date: January 5, 2023Inventors: HSIEH-HSUN HO, YI WEI KUO, KO-CHIANG HSIA, WEN-YANG LIN, JIA-HUNG LIN, CHI-HUEI LIN, CHENG-RUEI LIU, SHU-HUI CHEN